NCT05175677View on ClinicalTrials.gov

Study of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris Region

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

February 2, 2023

Conditions

COVID-19Diabetes Mellitus, Type 2

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors

lead

Fondation Hôpital Saint-Joseph

OTHER